Raras
Buscar doenças, sintomas, genes...
Arterite de Takayasu
ORPHA:3287CID-10 · M31.4CID-11 · 4A44.1OMIM 207600DOENÇA RARA

É uma doença inflamatória rara dos grandes vasos sanguíneos, que afeta principalmente a artéria aorta e seus principais ramos, mas também outros grandes vasos, causando estreitamento, bloqueio ou aneurisma.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença inflamatória rara dos grandes vasos sanguíneos, que afeta principalmente a artéria aorta e seus principais ramos, mas também outros grandes vasos, causando estreitamento, bloqueio ou aneurisma.

Pesquisas ativas
27 ensaios
75 total registrados no ClinicalTrials.gov
Publicações científicas
3.094 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
1.34
Europe
Início
Adolescent
+ adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: M31.4
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
8 sintomas
🩸
Sangue
3 sintomas
👁️
Olhos
2 sintomas
🧠
Neurológico
2 sintomas
🫁
Pulmão
2 sintomas
📏
Crescimento
2 sintomas

+ 30 sintomas em outras categorias

Características mais comuns

90%prev.
Arterite
Muito frequente (99-80%)
90%prev.
Fadiga
Muito frequente (99-80%)
90%prev.
Estenose arterial
Muito frequente (99-80%)
90%prev.
Perda de peso
Muito frequente (99-80%)
90%prev.
Morfologia anormal da válvula cardíaca
Muito frequente (99-80%)
90%prev.
Crise hipertensiva
Muito frequente (99-80%)
54sintomas
Muito frequente (9)
Frequente (24)
Ocasional (21)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 54 características clínicas mais associadas, ordenadas por frequência.

ArteriteArteritis
Muito frequente (99-80%)90%
FadigaFatigue
Muito frequente (99-80%)90%
Estenose arterialArterial stenosis
Muito frequente (99-80%)90%
Perda de pesoWeight loss
Muito frequente (99-80%)90%
Morfologia anormal da válvula cardíacaAbnormal heart valve morphology
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico3.094PubMed
Últimos 10 anos200publicações
Pico2025130 papers
Linha do tempo
2026Hoje · 2026🧪 1977Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

MLXMax-like protein XMajor susceptibility factor inTolerante
FUNÇÃO

Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MAD1, MAD4, MNT, WBSCR14 and MLXIP which recognizes the core sequence 5'-CACGTG-3'. The TCFL4-MAD1, TCFL4-MAD4, TCFL4-WBSCR14 complexes are transcriptional repressors. Plays a role in transcriptional activation of glycolytic target genes. Involved in glucose-responsive gene regulation

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
ChREBP activates metabolic gene expression
EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
71.6 TPM
Fibroblastos
70.5 TPM
Intestino delgado
66.4 TPM
Tecido adiposo
65.8 TPM
Tireoide
63.7 TPM
OUTRAS DOENÇAS (1)
Takayasu arteritis
HGNC:11645UniProt:Q9UH92
IL12BInterleukin-12 subunit betaMajor susceptibility factor inTolerante
FUNÇÃO

Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC Associates with IL23A to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates t

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (4)
Interleukin-10 signalingInterleukin-4 and Interleukin-13 signalingInterleukin-12 signalingInterleukin-23 signaling
MECANISMO DE DOENÇA

Immunodeficiency 29

A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. IMD29 is characterized by undetectable IL12B secretion from leukocytes. Affected individuals generally present with BCG disease after vaccination in childhood, and at least half also have Salmonella infection. Disease phenotype is relatively mild, and patients have a good prognosis.

EXPRESSÃO TECIDUAL(Baixa expressão)
Linfócitos
1.0 TPM
Pituitária
0.8 TPM
Testículo
0.1 TPM
Rim - Córtex
0.1 TPM
Glândula salivar
0.1 TPM
OUTRAS DOENÇAS (2)
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiencyTakayasu arteritis
HGNC:5970UniProt:P29460
HLA-BHLA class I histocompatibility antigen, B alpha chainMajor susceptibility factor inTolerante
FUNÇÃO

Antigen-presenting major histocompatibility complex class I (MHCI) molecule. In complex with B2M/beta 2 microglobulin displays primarily viral and tumor-derived peptides on antigen-presenting cells for recognition by alpha-beta T cell receptor (TCR) on HLA-B-restricted CD8-positive T cells, guiding antigen-specific T cell immune response to eliminate infected or transformed cells (PubMed:23209413, PubMed:25808313, PubMed:29531227, PubMed:9620674). May also present self-peptides derived from the

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
E3 ubiquitin ligases ubiquitinate target proteins
MECANISMO DE DOENÇA

Stevens-Johnson syndrome

A rare blistering mucocutaneous disease that share clinical and histopathologic features with toxic epidermal necrolysis. Both disorders are characterized by high fever, malaise, and a rapidly developing blistering exanthema of macules and target-like lesions accompanied by mucosal involvement. Stevens-Johnson syndrome is a milder disease characterized by destruction and detachment of the skin epithelium and mucous membranes involving less than 10% of the body surface area. Ocular symptoms include ulcerative conjunctivitis, keratitis, iritis, uveitis and sometimes blindness. It can be caused by a severe adverse reaction to particular types of medication, although Mycoplasma infections may induce some cases.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
8283.6 TPM
Baço
6025.1 TPM
Linfócitos
5071.2 TPM
Pulmão
4631.0 TPM
Intestino delgado
2873.0 TPM
OUTRAS DOENÇAS (7)
obsolete pulmonary arterial hypertension associated with connective tissue diseaseTakayasu arteritistemporal arteritisStevens-Johnson syndrome
HGNC:4932UniProt:P01889

Variantes genéticas (ClinVar)

62 variantes patogênicas registradas no ClinVar.

🧬 MLX: NM_198204.2(MLX):c.476+118G>T ()
🧬 MLX: NM_198204.2(MLX):c.476+24G>T ()
🧬 MLX: NM_198204.2(MLX):c.170-17C>G ()
🧬 MLX: NM_198204.2(MLX):c.42+167G>T ()
🧬 MLX: GRCh37/hg19 17q12-22(chr17:41196270-41277589) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado4
3Fase 31
2Fase 21
·Pré-clínico14
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Arterite de Takayasu

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

18 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

75 ensaios clínicos encontrados, 27 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
2.004 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 2.004

#1

Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.

Circulation journal : official journal of the Japanese Circulation Society2026 Feb 14

To provide evidence from randomized controlled trials (RCTs) for large-vessel vasculitis (LVV), including Takayasu arteritis (TAK) and giant cell arteritis (GCA), to inform the forthcoming 2026 Japanese Circulation Society (JCS) clinical practice guideline. We drafted 4 and 7 clinical questions for TAK and GCA, respectively. A systematic review (SR) of RCTs was conducted using PubMed, CENTRAL, EMBASE, and the Japan Medical Abstracts Society through March 2024. Assessed with the GRADE approach, the certainty of evidence was very low for the most critical outcomes, low for some outcomes, and moderate for only 1 outcome. Evidence for TAK was limited. Tocilizumab (TCZ) resulted in a numerically lower relapse rate vs. placebo (risk ratio (RR) 0.73, 95% confidence interval (CI) 0.39-1.37) and was similar to adalimumab. No clear difference between mycophenolate mofetil (MMF) and methotrexate (MTX), or between abatacept (ABA) and placebo was observed. In GCA, TCZ reduced relapse (RR 0.29, 95% CI 0.09-0.98) and increased remission (RR 3.56, 95% CI 2.29-5.54) over placebo at 52 weeks. Tumor necrosis factor inhibitor, ABA, and MTX showed no benefit in cranial GCA. Serious adverse events were comparable between treatment groups. Geographic variation and differences in entry criteria were noted. This SR was comprehensive synthesis of evidence from RCTs for LVV therapies to support the 2026 JCS guideline.

#2

Pregnancy complicated by Takayasu arteritis and recurrent pregnancy loss.

BMJ case reports2026 Jan 28

A young woman (G4P2L0A1) diagnosed with a case of Takayasu arteritis (Type IV) and a history of recurrent pregnancy loss presented at 7 weeks of gestation with chronic hypertension. She was on immunosuppressive and antihypertensive therapy preconceptionally. At 29 weeks, she developed a hypertensive emergency with stage 2 fetal growth restriction. Despite aggressive management, blood pressure (BP) remained elevated (up to 200/110 mm Hg). A preterm caesarean section was performed at 31 weeks under steroid cover, resulting in the delivery of a 1.45 kg male neonate. Both mother and baby had uneventful recoveries, and the patient achieved the target BP by discharge.

#3

Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.

Circulation2026 Jan 27

Takayasu arteritis (TAK) is a rare, immune-mediated large-vessel vasculitis that affects predominantly young women and carries a substantial risk of both vascular complications and long-term cardiovascular disease. Although glucocorticoids and conventional immunosuppressive therapies remain the cornerstone of treatment, relapse rates are high, and current strategies fail to adequately mitigate future cardiovascular risk. This review synthesizes evidence on current treatment strategies, unmet clinical needs, and novel approaches, including immunological and vascular-targeted therapies, and argues for a shift in management paradigm toward integrated cardiovascular risk reduction. We discuss advances in understanding the pathogenesis of TAK, highlighting the roles of innate and adaptive immunity in disease progression, and the challenges of early diagnosis and disease monitoring. We critically appraise current treatment paradigms, including glucocorticoids, conventional disease-modifying antirheumatic drugs, and biologics such as tocilizumab and tumor necrosis factor-α inhibitors, and outline emerging therapies targeting novel pathways, including interleukin-17, interleukin-12/23, Janus kinase/signal transducer and activator of transcription, and Notch-1/mammalian target of rapamycin complex signaling. We highlight the increasing recognition of cardiovascular morbidity as a major contributor to mortality in TAK and the need for integrated approaches to risk factor modification. We explore a road map for advancing management of cardiovascular disease in TAK, including comprehensive screening tools that integrate serological and imaging biomarkers to interrogate cardiovascular risk and potential therapeutic cardioprotective strategies such as sodium-glucose cotransporter 2 inhibitors and endothelin receptor antagonists. Despite recent progress, clinical management remains limited by diagnostic uncertainty, heterogeneous treatment approaches, and a paucity of high-quality randomized controlled trials. Future work should focus on interventions that target both immune-mediated vascular injury and cardiovascular disease progression. Achieving long-term disease remission while reducing cardiovascular mortality must become the primary therapeutic goal in TAK.

#4

[Analysis of follow-up and prognosis in pediatric rheumatic diseases associated with pulmonary embolism].

Zhonghua er ke za zhi = Chinese journal of pediatrics2026 Jan 02

Objective: To explore the clinical characteristics, diagnosis and treatment strategies, and prognosis of pulmonary embolism (PE) complicating childhood rheumatic diseases. Methods: A retrospective case series study was performed on the demographic data, laboratory indicators, imaging features, treatment regimens, and follow-up data of 8 children with rheumatic diseases complicated by PE who were admitted to the Department of Rheumatology and Immunology, Capital Center for Children's Health, Capital Medical University from January 2014 to October 2023. Results: Among the 8 children, there were 4 boys and 4 girls, with an age of 12.0 (7.5, 13.0) years. Among the primary diseases, there were 3 cases of systemic lupus erythematosus, 2 cases of Behçet's disease, 2 cases of Takayasu arteritis, and 1 case of antiphospholipid syndrome. All children developed PE during the active phase of the primary disease. PE was detected at the onset of the primary disease in 3 cases, and the median time from the diagnosis of the primary disease to the development of PE was 10.0 (6.0, 25.0) months in the remaining 5 cases. Fever was present in all 8 children, 4 cases were accompanied by chest tightness, dyspnea, etc., and 2 cases only presented with fever. Laboratory examinations revealed the following results: erythrocyte sedimentation rate was 42.0 (17.0, 78.0) mm/1 h, high-sensitivity C-reactive protein was 12.7 (2.6, 78.7) mg/L, white blood cell count was 9.6 (7.2, 18.7)×109/L; D-dimer was 2.3 (0.9, 6.2) mg/L; and hemoglobin was (109±16) g/L.Imaging examinations revealed that 5 cases had involvement of the bilateral lower pulmonary arteries, 5 cases had peripheral embolism, and 3 cases had central PE. Complications included 3 cases of deep vein thrombosis, 2 cases of intracranial venous sinus thrombosis, and 1 case of mild pulmonary hypertension.In terms of treatment, 7 cases received anticoagulation with heparin followed by warfarin. Immunomodulation was mainly based on glucocorticoids combined with immunosuppressants, and 4 cases were combined with biological agents. The follow-up time of 4.17 (1.75, 7.17) years, the time for complete absorption of PE was 10.5 (6.0, 18.0) months; all 8 children had no target events, with no recurrence or chronic thromboembolic pulmonary hypertension, and the pulmonary artery remodeling was good. Conclusions: PE complicating childhood rheumatic diseases is closely related to the activity of the primary disease. The clinical manifestations are insidious, with fever as the main symptom. Imaging examination is the key to diagnosis.Early adoption of heparin followed by warfarin anticoagulation and glucocorticoids combined with immunosuppressants and (or) biological agents to control the primary disease can achieve a favorable prognosis. 目的: 探讨儿童风湿病并发肺栓塞的临床特征、诊疗策略及预后。 方法: 回顾性病例系列研究,收集2014年1月至2023年10月首都医科大学附属首都儿童医学中心风湿免疫科收治的8例风湿病并发肺栓塞患儿的人口学资料、实验室指标、影像学特征、治疗方案及随访资料。 结果: 8例患儿中,男、女各4例,就诊年龄12.0(7.5,13.0)岁。8例患儿原发病中系统性红斑狼疮3例,白塞病2例、多发性大动脉炎2例、抗磷脂综合征1例。所有患儿均在原发病活动期发生肺栓塞,3例患儿于首次就诊时发现,5例患儿肺栓塞的发病时间距原发病确诊时间为10.0(6.0,25.0)个月。临床表现中发热8例,伴胸闷、呼吸困难4例等,2例患儿仅表现为发热。实验室检查显示8例患儿中红细胞沉降率42.0(17.0,78.0)mm/1 h,高敏C反应蛋白12.7(2.6,78.7)mg/L,白细胞计数9.6(7.2,18.7)×10⁹/L;D二聚体2.3(0.9,6.2)mg/L;血红蛋白(109±16)g/L。影像学检查示8例患儿中双下肺动脉受累5例,周围型栓塞5例,中心型肺栓塞3例;3例患儿合并深静脉血栓,2例伴颅内静脉窦血栓,1例轻度肺动脉高压。治疗方面7例患儿采用肝素序贯华法林抗凝,免疫调节以糖皮质激素联合免疫抑制剂为主,4例联用生物制剂。随访4.17(1.75,7.17)年,所有患儿肺栓塞完全吸收时间为10.5(6.0,18.0)个月,8例患儿经随访,均无目标事件发生,无复发或慢性血栓栓塞性肺动脉高压,肺动脉重构良好。 结论: 儿童风湿病并发肺栓塞与原发病活动密切相关,临床表现隐匿,以发热为主要表现,影像学检查是诊断关键,早期采用肝素序贯华法林抗凝及糖皮质激素联合免疫抑制剂和(或)生物制剂控制原发病可获良好预后。.

#5

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Circulation journal : official journal of the Japanese Circulation Society2026 Mar 20

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2.243 artigos no totalmostrando 197

2026

Coexistence of Sjögren's disease and Takayasu arteritis in a woman: a case-based review.

Clinical rheumatology
2026

Differential Vascular Response to Corticosteroid Therapy in Takayasu Arteritis Revealed by Serial FDG-PET Imaging.

European journal of nuclear medicine and molecular imaging
2026

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Circulation journal : official journal of the Japanese Circulation Society
2026

Management of Takayasu Arteritis - A 2026 Update.

Current rheumatology reports
2026

Therapeutic effect of tofacitinib combined with leflunomide for refractory Takayasu arteritis: pilot study.

Seminars in arthritis and rheumatism
2026

Hematopoietic Stem Cell Transplantation in Rheumatic Diseases.

International journal of rheumatic diseases
2026

Construction and internal cohort verification of clinical-imaging-based nomogram for early diagnosis in Takayasu arteritis.

Frontiers in medicine
2026

Unilateral Graves disease with Takayasu arteritis.

JCEM case reports
2026

Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database.

Arthritis research &amp; therapy
2026

Pathogenetic Gut Microbiota in Aortic Diseases: Evidence and Mechanisms Across Aneurysm, Dissection, and Inflammatory Aortopathies.

Nutrients
2026

The rheumatry registry: design and data collection methods.

BMC rheumatology
2026

Stent insertion for chronic total occlusion of the common carotid artery in a patient with Takayasu arteritis using an adjunctive retrograde approach via superficial temporal artery puncture: illustrative case.

Journal of neurosurgery. Case lessons
2026

Embolic Myocardial Infarction from Takayasu Arteritis.

CASE (Philadelphia, Pa.)
2026

Utility of contrast-enhanced ultrasound for assessing disease activity in takayasu arteritis with carotid artery involvement: a scoping review.

Frontiers in immunology
2026

Coexistence of Takayasu Arteritis and Intestinal Tuberculosis in a Young Bangladeshi Woman.

Clinical case reports
2026

Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patients.

Seminars in arthritis and rheumatism
2026

Definitions and online reliability assessment of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working Group.

Seminars in arthritis and rheumatism
2026

Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.

Circulation journal : official journal of the Japanese Circulation Society
2026

Deficiency of transcription factor E4BP4 suppresses neointimal formation after vascular injury.

Atherosclerosis
2026

Long-Term Follow-Up in Patients with Large-Vessel Vasculitis Applying Extracranial and Transcranial Duplex Sonography.

Diagnostics (Basel, Switzerland)
2026

Takayasu Arteritis Presenting With Cardiac Arrest: An Intravascular Imaging Triggered Diagnosis.

JACC. Case reports
2026

Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience.

RMD open
2026

Autoantibodies and B Cells in Takayasu Arteritis and Giant Cell Arteritis: Comparative Insights into Large-Vessel Vasculitis.

The Tohoku journal of experimental medicine
2026

Mesenteric Steal Syndrome Caused by Abdominal Aortic Stenosis due to Takayasu Arteritis.

Surgical case reports
2026

Beating the Odds: Successful Emergent Surgery After Acute Aortic Dissection in Takayasu Arteritis.

Cureus
2026

Internal carotid artery involvement and stroke risk in Takayasu arteritis: a case-control study.

Rheumatology international
2026

[Non-infectious neuroretinitis: diagnostic and therapeutic approach in unusual presentations].

Medicina
2026

A rare case of midaortic syndrome: Vascular Behçet's disease or Takayasu arteritis?

Turk gogus kalp damar cerrahisi dergisi
2026

Maternal and perinatal outcomes in vasculitis: a 15-year study at a Portuguese tertiary multidisciplinary centre.

Rheumatology advances in practice
2026

Intestinal obstruction associated with middle aortic syndrome: A case report.

The Journal of international medical research
2026

Clinical Images: Bilateral common iliac aneurysms in Takayasu arteritis with consequent obstructive uropathy.

Arthritis &amp; rheumatology (Hoboken, N.J.)
2025

Exploring the Correlations between Initial Clinical and Radiological Manifestations in Takayasu's Arteritis.

Arquivos brasileiros de cardiologia
2026

Reversal of chronic arterial stenosis with biologic therapy including tocilizumab in Takayasu arteritis.

Modern rheumatology case reports
2026

Therapeutic management of inflammatory heart diseases.

Pharmacology &amp; therapeutics
2026

Pregnancy complicated by Takayasu arteritis and recurrent pregnancy loss.

BMJ case reports
2026

Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.

Circulation
2025

Subclavian artery stenosis in hemodialysis patients: a case series and review of the literature.

Frontiers in pharmacology
2026

Erdheim-Chester disease mimicking IgG4-related disease.

Modern rheumatology case reports
2026

Takayasu Arteritis-Induced Acute Myocardial Infarction: Coronary Imaging- and Physiology-Guided Management.

JACC. Case reports
2026

Proximal Right Coronary Artery Stenosis Secondary to Surgical Suture After Aortic Root Replacement.

JACC. Case reports
2026

Distinguishing Takayasu Arteritis and Giant Cell Arteritis Based on Large-Vessel Involvement Patterns.

Yonsei medical journal
2026

Claudication and Hypertension From Aortic Occlusion in Takayasu Arteritis: Revascularization With Excimer Laser and Drug-Eluting Stent.

Vascular and endovascular surgery
2026

Takayasu Arteritis in a Middle-aged Woman Following Prolonged Subsequent Fever after COVID-19 Infection: An Early Diagnosis Using Contrast-Enhanced CT.

Internal medicine (Tokyo, Japan)
2026

Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective Study.

ACR open rheumatology
2026

Takayasu Arteritis Presenting as Stress-Induced Chest Pain.

Mayo Clinic proceedings
2026

Association of genetic variants with extravascular complications and cytokine production in Takayasu arteritis: a cross-sectional study.

Rheumatology advances in practice
2026

Chest pain in an adolescent revealing a sinus of Valsalva aneurysm secondary to Takayasu arteritis.

Cardiology in the young
2025

Silent inflammation, stormy presentation: bilateral renal artery stenosis secondary to Takayasu arteritis.

The Journal of invasive cardiology
2025

Immunosuppressive Therapy in Takayasu Arteritis: A Tightrope Walk Between Inflammation and Infection.

Cureus
2025

Diverse Vascular Manifestations of Takayasu Arteritis: Coronary Artery Stenosis and Aneurysmal Dilation in pediatric patients.

Clinical medicine insights. Arthritis and musculoskeletal disorders
2025

Clinical Implications of Vasculitis Associated with Familial Mediterranean Fever: A Comparative Study in Childhood.

Modern rheumatology
2025

Takayasu Arteritis in a 55-Year-Old Woman With Prior Mycobacterium leprae Infection: A Possible Postinfectious Association.

Clinical case reports
2025

Severe Pediatric Takayasu Arteritis Presenting With Cerebral Ischemia and Supra-Aortic Trunk Occlusion.

Cureus
2026

Postpartum watershed strokes as initial manifestation of a rare co-occurrence of systemic lupus erythematosus and Takayasu Vasculitis: A case report of neuroimmunologic and literature review.

eNeurologicalSci
2026

[Analysis of follow-up and prognosis in pediatric rheumatic diseases associated with pulmonary embolism].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Case Report: Takayasu Arteritis During Upadacitinib Therapy for Ulcerative Colitis Successfully Treated by Combination Therapy With Methotrexate.

International journal of rheumatic diseases
2025

A case of Takayasu arteritis with advanced macrovascular lesions due to 6 years from onset to diagnosis.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Incidence of pulmonary hypertension in patients with Takayasu's arteritis: A transthoracic echocardiographic evaluation.

Reumatologia clinica
2025

Carotid sonographic features in Takayasu's arteritis: A case-control study.

Caspian journal of internal medicine
2025

Involvement of Iliofemoral Arteries in PET/CT Is Associated with Atherosclerotic Risk Factors in Takayasu's Arteritis.

Journal of clinical medicine
2025

Concurrent seronegative spondyloarthropathy and Takayasu's arteritis: a case report and literature review.

Diagnostic pathology
2025

Improving outcomes in proximal anastomosis: A challenging case of coronary revascularization in Takayasu arteritis.

JTCVS techniques
2026

Clinical and laboratory predictors of diagnostic delay in childhood Takayasu arteritis and PAN: a retrospective cohort study.

Rheumatology (Oxford, England)
2026

FAPI PET in the Diagnosis and Management of Inflammatory Diseases: Clinical Value and Future Perspectives.

Clinical nuclear medicine
2025

[Annuloaortic Ectasia Induced by Takayasu's Arteritis:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery
2025

A Case of Isolated Aortic Regurgitation, Later Diagnosed as Takayasu Arteritis: An Importance of Physical Examinations.

Clinical case reports
2025

Maternal-fetal outcomes and therapeutic strategies in pregnancies complicated by Takayasu arteritis: a comprehensive analysis.

Arthritis research &amp; therapy
2026

Large Vessel Vasculitis: Multimodality Imaging Findings and Technical Principles.

Radiographics : a review publication of the Radiological Society of North America, Inc
2025

Endovascular repair of infrarenal aortic aneurysm and severe stenosis in Type V Takayasu arteritis: a rare case report and clinical insights.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
2025

Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis.

Frontiers in immunology
2025

Open surgical revascularization after IL-6 blockade for Takayasu arteritis: A case report.

International journal of surgery case reports
2025

Hyperinflammatory status associated with COVID-19: clinical features of a pediatric series.

Advances in rheumatology (London, England)
2025

Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study.

Blood cancer journal
2026

Cardioembolic stroke in Takayasu arteritis treated with dual stent retriever via brachial access: A case report.

Radiology case reports
2025

The Role of Imaging in Monitoring Large Vessel Vasculitis: A Comprehensive Review.

Biomolecules
2025

Applications and challenges of paclitaxel- coated balloons beyond coronary atherosclerotic heart disease.

World journal of clinical cases
2025

Adolescent-Onset Takayasu Arteritis with Vertebral Steal Syndrome and Non-bifurcating Carotid Arteries: A Rare Case from Pakistan.

Clinical medicine insights. Case reports
2025

Technical Tips for Surgical Treatment of Takayasu Arteritis.

Vascular specialist international
2026

Physical activity in systemic vasculitis.

European journal of internal medicine
2025

The Role of FDG-PET in the Diagnosis and Monitoring of Large-Vessel Vasculitis.

Current rheumatology reports
2025

Postpartum Hybrid Aortic Aneurysm Repair in the Setting of Takayasu Arteritis.

The Annals of thoracic surgery
2025

A Rare Case of Takayasu Arteritis and Aortic Aneurysm in a Male Patient.

Cureus
2025

Advancing the understanding of age-specific phenotypes in childhood-onset takayasu arteritis.

Pediatric research
2026

ANK2-MAVS signaling dysfunction triggers mitochondrial stress and enhances IL-8 mediated inflammatory responses in Takayasu arteritis.

Free radical biology &amp; medicine
2026

A visual guide for emergency radiologists navigating the complexity of abdominal vasculitis: part 1 - true vasculitis.

Emergency radiology
2025

[Expert consensus for the diagnosis and treatment of pediatric Takayasu arteritis (2025)].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Integrated bulk and single-cell transcriptomics identifies shared and specific immune signatures in Takayasu Arteritis.

Arthritis research &amp; therapy
2025

Therapeutic plasma exchange in autoimmune diseases: a retrospective study in a tertiary pediatric hospital in Mexico.

Frontiers in pediatrics
2025

Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis.

Journal of autoimmunity
2025

Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis.

Nature reviews. Rheumatology
2025

Syphilitic Cardiac and Vascular Disease: A Comprehensive Review.

Cardiology in review
2025

Takayasu arteritis presenting with severe biventricular dysfunction and renal artery stenosis in a pediatric patient: a case report.

Annals of medicine and surgery (2012)
2025

Beyond the Pulselessness: A Multifaceted Case of Takayasu Arteritis With Aneurysmal Complications and Extensive Upper Limb Vascular Occlusion in a 40-Year-Old Female.

Clinical case reports
2025

Development of Successive Thrombophlebitis and Takayasu Arteritis Associated With Crohn Disease in a Pediatric Patient: A Case Report.

The Journal of rheumatology
2025

Clinical Course After Transcatheter Aortic Valve Replacement for Takayasu Arteritis-Related Aortic Stenosis and Regurgitation.

JACC. Case reports
2026

Vasculitis syndromes: large vessel vasculitides and ANCA-associated vasculitides from a neuroradiologist's perspective.

Japanese journal of radiology
2026

IL-1R/IL-6R blockade for null NLRP12 variant-carrying Takayasu arteritis.

Rheumatology (Oxford, England)
2025

An alternative catheter to invasive blood pressure monitoring in a patient with Takayasu arteritis undergoing open adrenalectomy: A case report.

Medicine
2025

Takayasu retinopathy unveiling underlying Takayasu arteritis: a case report.

BMC ophthalmology
2025

Macaroni Sign in Takayasu Arteritis.

Mediterranean journal of rheumatology
2025

[Granuloma faciale and Takayasu arteritis in a child: a case report].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Clinical profile and long-term outcomes of pediatric-onset Takayasu's arteritis: data from a mexican national referral center.

Pediatric rheumatology online journal
2025

Gene variants of glucocorticoid activation pathways and the outcomes of patients with Takayasu arteritis - a retrospective cohort study.

Frontiers in immunology
2025

Serum interleukin-1 receptor antagonist levels are a useful marker of disease activity and risk of relapse in large vessel vasculitis.

Cytokine
2026

Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.

Rheumatology (Oxford, England)
2025

[Clinical characteristics and prognosis of childhood-onset Takayasu arteritis involving pulmonary artery].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Diagnostic delay and cardiovascular complications in Takayasu arteritis: a case-based review.

Rheumatology international
2026

Treatment of systemic vasculitis.

Current opinion in rheumatology
2025

Posterior Reversible Encephalopathy Syndrome in a Young Female with Takayasu and Tubercular Arteritis: A Rare Case Report.

Annals of African medicine
2025

An Atypical Presentation of Takayasu Arteritis: Isolated Tinnitus Followed by Ectopic Pregnancy.

Cureus
2025

Long-term outcomes of aortic valve insufficiency in patients with Takayasu arteritis.

Frontiers in immunology
2025

Childhood-onset Takayasu arteritis: Unique characteristics and outcomes from a Singapore cohort.

Annals of the Academy of Medicine, Singapore
2025

New avenues in childhood vasculitis.

Pediatric rheumatology online journal
2025

Pregnancy in Takayasu Arteritis: A Case Report of Successful Pregnancy in a Large Aortic Aneurysm.

Clinical case reports
2025

The role of 18F-fluorodeoxyglucose positron emission tomography for vascular imaging.

Progress in cardiovascular diseases
2025

A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.

Cureus
2025

Comparison of the 2022 ACR/EULAR classification criteria with the 1990 ACR classification criteria for Takayasu arteritis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
2026

Meta-Analysis of Carotid Contrast-Enhanced Ultrasonography to Assess the Activity of Takayasu Arteritis.

Journal of clinical ultrasound : JCU
2025

Childhood-onset Takayasu arteritis: clinical presentation, challenges and disease course.

Pediatric rheumatology online journal
2025

Superior Aortic Recess Mimicking Takayasu Arteritis in a Patient With Adult-Onset Still's Disease.

Cureus
2026

High prevalent early damage independently predicts future mortality in an inception cohort of Takayasu arteritis.

Rheumatology (Oxford, England)
2025

Age specific clinical manifestations and vascular involvements in childhood-onset Takayasu arteritis.

Pediatric research
2025

Optic Disc and Retinal Structural Changes in Takayasu Arteritis: Implications for Normotensive Glaucoma.

Ocular immunology and inflammation
2025

Prevalence and clinical severity of takayasu arteritis angiographic types: a systematic review with meta-analysis.

Rheumatology international
2025

Problem analysis based on the international classification of functioning, disability and health (ICF) in patients with Takayasu arteritis.

Respiratory medicine
2026

Phenotypic clusters of patients with Takayasu arteritis predict disease activity at presentation, damage and future vascular complications.

Rheumatology (Oxford, England)
2025

Diagnostic Accuracy of Clinical Findings for Takayasu Arteritis: A Rapid Review and Meta-Analysis.

International journal of vascular medicine
2026

Aortitis in Disguise: Cardiomyopathy in a Child With Takayasu Arteritis.

Circulation. Cardiovascular imaging
2025

Takayasu Arteritis with Fistulizing Crohn's Disease: A Rare Presentation.

The Journal of the Association of Physicians of India
2025

Beyond the Norm: Recognizing Uncommon Presentations of Large Vessel Vasculitis.

The Journal of the Association of Physicians of India
2025

Incomplete Susac Syndrome With Recurrent Retinal Occlusions and Vertigo: A Case of Early Immunosuppressive Success.

Cureus
2025

Hybrid Endovascular Repair of Complex Abdominal Aortic Aneurysms in Takayasu Arteritis.

JACC. Case reports
2025

Concomitant Diagnosis and Therapeutic Response of Large-vessel Vasculitis and Hodgkin Lymphoma on 18 F-FDG PET/CT.

Clinical nuclear medicine
2026

Navigating complex clinical decisions: kidney transplantation following abdominal aorto-aortic bypass in infantile Takayasu arteritis.

Pediatric nephrology (Berlin, Germany)
2026

Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective study.

Immunological medicine
2025

Macaroni sign and Takayasu arteritis: point-of-care ultrasound utility.

Revista clinica espanola
2025

Secondary amyloidosis as a cause of nephrotic syndrome in Takayasu arteritis.

BMJ case reports
2025

Acute Myocardial Infarction as the First Clinical Presentation of Takayasu Arteritis in a 20-Year-Old Woman.

JACC. Case reports
2025

Severe Diffuse Takayasu Arteritis Manifestation in Childhood.

JACC. Case reports
2025

The fragility of randomized controlled trials in large vessel vasculitis.

Autoimmunity reviews
2025

A retrospective cohort study of 203 patients with Takayasu arteritis: experience from a Brazilian tertiary center.

Advances in rheumatology (London, England)
2025

Novel presentation of Takayasu arteritis in a young girl: severe dystonia, stroke and left ventricular thrombus.

BMJ case reports
2025

Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study.

Seminars in arthritis and rheumatism
2025

Cardiac disease in patients with vasculitis.

Clinical research in cardiology : official journal of the German Cardiac Society
2025

Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis.

Annals of the rheumatic diseases
2025

Renal Artery Involvement in Pediatric-Onset Takayasu Arteritis: Renal Characteristics and Mid-Term Follow-up Outcomes.

Klinische Padiatrie
2025

Takayasu Arteritis Following Necrotizing Fasciitis: A Case Report and Brief Review of the Literature.

Cureus
2025

Acute left heart failure is the initial manifestation of Takayasu arteritis: a case report.

BMC cardiovascular disorders
2025

The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review.

Reumatismo
2025

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study.

Rheumatology (Oxford, England)
2025

A rare case of severe bilateral chorioretinal coccidioidomycosis in an immunocompromised pediatric patient with Takayasu Arteritis.

American journal of ophthalmology case reports
2025

High ischemic deficit in computed tomography perfusion is a risk factor for cerebral vascular ischemic events in Takayasu arteritis: a prospective observational study.

BMC rheumatology
2025

Arteritic Anterior Ischemic Optic Neuropathy in Takayasu Arteritis: An Ominous Systemic Sign?

Journal of ophthalmic &amp; vision research
2025

Optimizing ultrasound evaluation of carotid artery stenosis in Takayasu's Arteritis: a focus on residual inner diameter as a key parameter.

Clinical rheumatology
2025

Systematic review and meta-analysis of the importance of pre-pregnancy maternal health on the risk of hypertensive disorders of pregnancy.

Pregnancy hypertension
2025

Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review.

Seminars in arthritis and rheumatism
2026

Strengthening the Prediction Model for Cardiovascular Events in Takayasu Arteritis: Future Directions and Enhancements.

The Canadian journal of cardiology
2026

Takayasu arteritis masquerading as an isolated sinus of valsalva dissection in a young adult.

Journal of echocardiography
2025

A Rare Case of Takayasu Arteritis Presenting With Syncope and Elevated Inflammatory Markers in an Elderly Male With Learning Disability.

Cureus
2025

Aortic dissection in a patient with Takayasu arteritis accompanied by pericardial effusion and atrioventricular block: A case report.

SAGE open medical case reports
2025

Interventions Related to Takayasu Arteritis, their Clinical and Angiographic Associations, and Prognostic Relevance - A Cohort Study.

Mediterranean journal of rheumatology
2025

A case of concomitant systemic lupus erythematosus and Takayasu arteritis.

Rheumatology advances in practice
2026

Predictors of Cardiovascular Events in Patients With Takayasu Arteritis: A Real-World Study.

The Canadian journal of cardiology
2026

An update on stroke and transient ischemic attack in Takayasu arteritis: A systematic review and meta-analysis.

Joint bone spine
2025

NASCI case of the month: "the role of FDG PET-CT in detecting active Takayasu arteritis".

The international journal of cardiovascular imaging
2025

Non-Aorto-Ostial Takayasu Arteritis Presenting as Exertional Chest Pain and Syncope Resulting in Coronary Artery Bypass Surgery in a Teenager.

Cureus
2026

A Well Built Risk Model in Takayasu Arteritis: Strengths Acknowledged, Gaps Remain.

The Canadian journal of cardiology
2025

Takayasu Arteritis on Ultra-Widefield Imaging.

JAMA ophthalmology
2025

Development of Takayasu arteritis during deep molecular response of chronic myeloid leukaemia: a case report and literature review.

Modern rheumatology case reports
2025

Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritis.

Clinical and experimental rheumatology
2025

Challenging diagnosis of chronic myelomonocytic leukemia (CMML) in a patient with Takayasu arteritis: case report.

Leukemia &amp; lymphoma
2025

Echocardiographic evaluation of Takayasu arteritis including speckled tracking echocardiography and aortic stiffness.

Indian heart journal
2025

Transseptal Guidewire Stabilization to Facilitate Endograft Delivery During Thoracic Endovascular Aortic Repair of a Giant Tortuous Thoracic Aortic Aneurysm.

JACC. Case reports
2025

Validation and clinical application of 2022 ACR/EULAR criteria for Takayasu arteritis in a large Chinese cohort.

Rheumatology (Oxford, England)
2025

Case Report: Can early full-course tocilizumab therapy reverse vascular stenosis in Takayasu arteritis?

Frontiers in immunology
2025

Supra-aortic Percutaneous Interventions in Takayasu Arteritis: Time to Liberalise Indications.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
2025

Beyond Atherosclerosis: Takayasu Arteritis Presenting as Ischemic Stroke in a Young Patient With Significant Traditional Vascular Risk Factors.

Cureus
2025

Upper extremity function and strength, assessed with unsupported upper limb exercise test, is impaired in patients with Takayasu arteritis.

Modern rheumatology
2025

Takayasu arteritis with a ruptured intracranial aneurysm in a pediatric patient: illustrative case.

Journal of neurosurgery. Case lessons
2025

Imaging features of Takayasu arteritis in a young male.

European heart journal. Imaging methods and practice
2025

Asymptomatic hypertension and bilateral renal artery stenosis in Takayasu arteritis.

ACR open rheumatology
2025

Complete obliteration of abdominal aorta with collateral circulation in Takayasu arteritis.

Clinical rheumatology
2025

Complex Presentation of Takayasu Arteritis in a Young Female: A Diagnostic Dilemma.

JACC. Case reports
2025

When the Vessels Whisper: The Power of Multimodality Imaging in Takayasu Arteritis.

JACC. Case reports
2025

Endovascular Therapy for Supra-aortic Artery Stenosis Caused by Takayasu's Arteritis: Long Term Results.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
2025

Collateral Rescue, Arterial Burden: Untreated Takayasu Arteritis and its Long-Term Complications.

Mediterranean journal of rheumatology
2025

Elevated soluble CD226 in Takayasu arteritis is useful for differentiation from giant cell arteritis, disease activity assessment, and prognosis prediction.

Medicine
2025

Unveiling the silent echoes: Multiple sinus of valsalva aneurysms as a rare cardiac imprint of Takayasu arteritis depicted on CT angiography.

Journal of cardiovascular computed tomography
2025

Hepatovascular manifestation of Takayasu arteritis presenting as sudden cardiac death.

Journal of forensic and legal medicine
2025

A 50-Year Delay in the Diagnosis of Takayasu Arteritis: Clinical Presentation and Therapeutic Insights.

Cureus
2025

Takayasu's Arteritis with Systemic Lupus Erythematosus: A Case Report.

Clinical Medicine Insights. Cardiology
2025

A Systematic Review of Anti-TNF and Anti-IL-6 Treatments for Pediatric Takayasu Arteritis: Addressing a Therapeutic Dilemma.

Paediatric drugs
2025

Cardiac Insights in Takayasu's Arteritis: Echocardiographic Differences in Active Takayasu Arteritis.

Echocardiography (Mount Kisco, N.Y.)
2025

Coronary Ostial Angioplasty for Takayasu Arteritis Using External Iliac Artery Graft: 1-year Follow-up.

Annals of thoracic surgery short reports
2025

Cerebral Perfusion Features in Takayasu Arteritis: Insights From pCASL MRI.

International journal of rheumatic diseases
2025

Median arcuate ligament syndrome (MALS) in a patient with Takayasu Arteritis.

Medicina clinica
2025

Macaroni Sign: Point-of-Care Ultrasound Identification of Takayasu Arteritis.

The American journal of medicine
Ver todos os 2.243 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Arterite de Takayasu.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Arterite de Takayasu

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.
    Circulation journal : official journal of the Japanese Circulation Society· 2026· PMID 41692437mais citado
  2. Pregnancy complicated by Takayasu arteritis and recurrent pregnancy loss.
    BMJ case reports· 2026· PMID 41605550mais citado
  3. Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
    Circulation· 2026· PMID 41587271mais citado
  4. [Analysis of follow-up and prognosis in pediatric rheumatic diseases associated with pulmonary embolism].
    Zhonghua er ke za zhi = Chinese journal of pediatrics· 2026· PMID 41401925mais citado
  5. JCS 2026 Guideline on Management of Large Vessel Vasculitis.
    Circulation journal : official journal of the Japanese Circulation Society· 2026· PMID 41866178mais citado
  6. [Pathomorphological features of various etiological forms of aortic aneurysm].
    Arkh Patol· 2026· PMID 41989545recente
  7. A Silent Vasculitis With a Loud Presentation: Takayasu Arteritis Causing Intracerebral Hemorrhage.
    Cureus· 2026· PMID 41988610recente
  8. Carotid steal syndrome with recurrent syncope: A novel manifestation of Takayasu arteritis.
    Glob Cardiol Sci Pract· 2025· PMID 41978897recente
  9. Burned out Takayasu arteritis in a young caucasian female: A rare case of aortic regurgitation and aneurysm requiring surgical repair.
    Glob Cardiol Sci Pract· 2025· PMID 41978713recente
  10. Metabolic-Epigenetic Crosstalk in Takayasu Arteritis: The ANK2-MAVS-IL-8 Axis as a Novel Therapeutic Paradigm.
    Int J Mol Sci· 2026· PMID 41977430recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:3287(Orphanet)
  2. OMIM OMIM:207600(OMIM)
  3. MONDO:0017991(MONDO)
  4. GARD:7730(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q432462(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Arterite de Takayasu
Compêndio · Raras BR

Arterite de Takayasu

ORPHA:3287 · MONDO:0017991
Prevalência
1-9 / 100 000
Herança
Not applicable
CID-10
M31.4 · Síndrome do arco aórtico [Takayasu]
CID-11
Ensaios
27 ativos
Início
Adolescent, Adult
Prevalência
1.34 (Europe)
MedGen
UMLS
C0003490
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades